Background: Nephrotoxicity is the major side-effect of cisplatin (CDDP), and it is reported to be gender-related. We evaluated the effects of pomegranate flower extract (PFE) as an antioxidant on CDDP-induced nephrotoxicity in female rats.
INTRODUCTION
Cisplatin (CDDP), as an antitumor drug, is widely used for chemotherapy. [1] CDDP-induced nephrotoxicity is related to its accumulation in the proximal tubule cells, [2] and synthetic or herbal agents have been investigated as supplementations against CDDP-induced nephrotoxicity. [3, 4] Previous studies showed that some antioxidant agents have protective effect against CDDP-induced nephrotoxicity in male but not in female [5] [6] [7] while nephrotoxicity induced by CDDP may be gender-related, [8, 9] and presence of estrogen aggravates nephrotoxicity induced by CDDP in ovariectomized female rats. [10] [11] [12] Herbs are often administrated in combination with chemical drugs, which may enhance the potential of herb-drug antioxidant activity. [13] Several flavonoids, including quercetin and some other polyphenols are found in Morus alba, Zingiber, and garlic, which have been used against kidney toxicity induced by nephrotoxins.
Pomegranate has antioxidant, antiinflammatory, and antimicrobial effects. [17] [18] [19] [20] Thus, the current study was designed to investigate whether pomegranate flower extract (PFE) could have nephroprotective role against CDDP in female rats.
METHODS
To prepare PFE, 500 g of pomegranate flower was provided and powdered. The hydroalcoholic extract was prepared by ethanol:water (70:30) mixture using percolation method. The extract was concentrated and dried to obtain 123 g pure powder. Total phenolic content of the extract was estimated by the Folin-Ciocalteu method. Briefly, 20 µl extract 85% plus 1.58 ml deionized water and 100 µl Folin-Ciocalteu reagents were mixed. After 30 s, 30 µl Na 2 CO 3 was added to the mixture and incubated at 20°C for 2 h. Finally, the absorbance was read at 765 nm. Total phenolic content of the extract was reported to be 9.98% of gallic acid.
Twenty-three adult female Wistar rats weighting 166.1 ± 2.3 g in four groups were housed at the temperature of 23-25°C, and they had free access to water and rat chow. They were treated as following. Groups 1 (n = 6) and 2 (n = 6) respectively received PFE at the doses of 25 and 50 mg/kg/day for 9 days, and from day 3 on they also received CDDP (2.5 mg/kg/day, intraperitoneal injection). CDDP was purchased from EBEWE Pharma Ges.m.b.H, Austria. Group 3 (n = 6) was treated as group 1 expect saline instead of PFE, and group 4 (n = 5) received PFE (25 mg/kg/day) alone. At the end of the study, all animals were sacrificed after blood sampling. The kidneys and uterus were excised and weighed immediately. The left kidney was used for histopathological investigations via hematoxylin and eosin staining. The intensity of tubular injuries was graded by a pathologist from 1 to 4, while zero score was assigned to normal tissue without damage.
Serum levels of creatinine (Cr) and blood urea nitrogen (BUN) were determined using quantitative diagnostic kits (Pars Azmoon, Iran). The serum level of nitrite (stable NO metabolite) was measured using a colorimetric assay method that involves the Griess reaction. Serum and kidney levels of malondialdehyde (MDA) were quantified according to the manual method.
Statistical analysis
The data obtained are presented as mean ± standard error of the mean. The quantitative data was compared by analysis of variance using latent difference score as the posttest. Since the scoring was qualitative, the Mann-Whitney test was applied to compare the pathology damage scores among the groups. P < 0.05 was considered as statistically significant.
RESULTS
CDDP induced body weight loss and increased kidney weight significantly (P < 0.05). This agent itself also significantly elevated the serum levels of BUN, Cr, and nitrite; and also kidney tissue damage score (P < 0.05). Furthermore, it increased the serum level of MDA insignificantly but it did not alter the uterus weight. Administration of PFE did not ameliorate the levels of the aforementioned parameters. However, combination of PFE and CDDP increased and decreased the serum levels of BUN and nitrite, respectively (P < 0.05) [ Figure 1 ].
DISCUSSION
Today, employment of herbal compounds has become an accepted approach to ameliorate side effects induced by chemotherapy drugs. [21, 22] Pomegranate contains polyphenols and antioxidant capacity. [23] [24] [25] [26] The main purpose of this study was to investigate the protective role of PFE against CDDP-induced nephrotoxicity in female rats. Our results showed that PFE had no protective effect on nephrotoxicity induced by CDDP in female rats. Recently, we had performed a series of studies to investigate the role of gender difference in nephrotoxicity induced by CDDP. [6, 7, 9] We showed that CDDP-induced nephrotoxicity is gender-related, and males are vulnerable more than females. [10, 11] CDDP induced nephrotoxicity due to free radicals and reactive oxygen species that are involved in CDDP-induced oxidative stress. [27] Previously, we used both single (7 mg/kg) and continuous dose of CDDP in female rats [5] [6] [7] [8] [9] 28] which was accompanied with different responses. Moreover, administration of PFE did not ameliorate tissue damage and renal dysfunction. Antioxidants such as losartan, Vitamin E, Vitamin C, and L-argentine did not ameliorate nephrotoxicity induced by CDDP in female rats while they were nephroprotective in male rats. [6, 10, 29] Evidences also showed that the presence of estrogen may alter the effects of these supplementations. [10, 11] It is reported that the low dose of PFE 25 mg/kg/day exhibits a protective role against CDDP in male rats, [30] however such results was not seen in the current study in female rats.
Nitric oxide, as a vasodilator agent, involves in kidney circulation. [31] CDDP-induces endothelial dysfunction and increases inducible nitric oxide synthase (iNOS) level and iNOS involves in CDDP-induced toxicity. [32, 33] We observed that CDDP increases the serum level of nitrite probably by increasing the iNOS level, but PFE could ameliorate this increase. This finding is in agreement with other studies, which indicated the effect of pomegranate juice on NO level. [34] 
CONCLUSIONS
It is concluded that administration of PFE not only did not ameliorate nephrotoxicity induced by CDDP in female rats, but also aggravated renal damage, while the extract was protective against CDDP in male rats. [30] 
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Figure 1:
Serum levels of blood urea nitrogen, creatinine, malondialdehyde, and nitrite; weight change, kidney weight/100 g body weight, uterus weight/100 g body weight and kidney tissue damage score in the four experimental groups. *and # indicate significant difference from pomegranate flower extract 25 and concentrated pomegranate groups, respectively (P < 0.05)
